Seer Inc

Historical price data

Seer is a commercial-stage proteomics company focused on making the proteome—the entire set of proteins in a biological system—broadly accessible to researchers and clinicians. Its core technology, the Proteograph Product Suite, utilizes engineered nanoparticles and liquid chromatography-mass spectrometry (LC-MS) to perform deep, unbiased, and rapid proteomic analysis from minimal sample volumes. The company aims to transform the understanding of biology and disease by providing scalable tools that overcome the historical limitations of proteomics, positioning itself at the forefront of the next generation of life science research and diagnostics.

The Proteograph Product Suite, an integrated workflow using engineered nanoparticles and LC-MS for unbiased, deep-scale, and high-throughput proteomic analysis from minimal sample volumes.

Seer competes with established proteomics tools companies like Thermo Fisher (and its Olink division) and Bruker, as well as specialized firms like SomaLogic (Standard BioTools). Its main differentiation is offering unbiased, deep-scale proteomic discovery at a throughput that bridges a gap in the existing market, but it must convince customers to adopt its new workflow over familiar, high-plex targeted assays.